← Back to Clinical Trials
Recruiting NCT05877391

NCT05877391 Intervention to Collect and Utilize Sexual Orientation and Gender Identity (SOGI) Information in Hospice

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05877391
Status Recruiting
Phase
Sponsor University of Colorado, Denver
Condition Sexual and Gender Minorities
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2023-03-13
Primary Completion 2027-09

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
SGM Communication Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2023-03-13 with a primary completion date of 2027-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Older sexual and gender minority (SGM) patients are at risk for receiving inequitable end-of-life care; those with Alzheimer's disease and related dementias (ADRD) are at particularly high risk. Failure to collect and integrate sexual orientation and gender identity (SOGI) data to identify patients' informal support systems may have adverse health consequences for SGM older adults, particularly for those dependent on informal caregivers to provide in-home support and assist with activities of daily living. The goal of this K01 is develop a novel training for hospice staff in person-centered communication that includes SOGI data collection to promote authentic end-of-life care for SGM patients and their caregivers.

Eligibility Criteria

Inclusion Criteria: * English speaking * 18 years and above Exclusion Criteria: --People under 18, pregnant women, prisoners, and people who are decisionally challenged will be excluded from the study.

Contact & Investigator

Central Contact

Carey Candrian, PhD

✉ carey.candrian@cuanschutz.edu

📞 3037247892

Frequently Asked Questions

Who can join the NCT05877391 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Sexual and Gender Minorities. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05877391 currently recruiting?

Yes, NCT05877391 is actively recruiting participants. Contact the research team at carey.candrian@cuanschutz.edu for enrollment information.

Where is the NCT05877391 trial being conducted?

This trial is being conducted at Aurora, United States.

Who is sponsoring the NCT05877391 clinical trial?

NCT05877391 is sponsored by University of Colorado, Denver. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology